Welcome Message
 
Our Company
 
Awards & Recognition
 
Corporate Governance
 
Management Council
Board of Directors
Reports of Insider Transactions
Committee Charters
Corporate Governance Guidelines
Additional Policies and Guidelines
Codes of Conduct
Articles of Incorporation (PDF)
Bylaws (PDF)
 
Corporate Compliance
 
Our Websites
 
Business Links

 

  » BMS.com Home » About Us » Corporate Governance » Jean-Marc Huet
SEARCH INDEX
 





Jean-Marc Huet

Senior Vice President and Chief Financial Officer

Jean-Marc HuetJean-Marc Huet is responsible for the company's worldwide finance operations, including Tax, Treasury, Control, Investor Relations, Internal Audit and Financial Shared Services.

Jean-Marc joined the company on March 31, 2008. His vision is to execute the company’s strategy of transformation into a leading next-generation BioPharma company. “We must build upon our leadership position today to make sure that we’re as strong and resilient as possible over the next five years. By being transparent, by being agile, by really focusing on our core competencies and our mission to extend and enhance human life, we will stand out from all the other pharmaceutical and health care companies.”

Previously, Jean-Marc was chief financial officer for Royal Numico N.V., Amsterdam, where he spearheaded Numico’s financial restructuring and acquisition strategy that led to a significant increase in market capitalization. Prior to joining Royal Numico, he was executive director of Investment Banking Services at Goldman Sachs International in London. Jean-Marc also spent several years at Clement Trading in Milan, Italy, as a commercial manager.

Jean-Marc enjoys challenges, both in his career and his personal life. His passions are skiing and motorbiking. “I love the mountains. My wife and I ski together and we’ve motorcycled through the Himalayas. It’s just a wonderful, wonderful way of life in the mountains.”

Jean-Marc Huet holds an MBA from INSEAD, Fontainebleau, France, and a bachelor’s degree from Dartmouth College. He is married with two preschool children.

May, 2008




[Top Page] [Search] [Index] [Contact] [Home]

Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.

© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.

 

SEARCH INDEX